131 related articles for article (PubMed ID: 9827442)
1. [Ischemic stroke in young patients and/or livedo: is it important to look for anti-beta 2-glycoprotein I antibodies?].
Granel F; de Maistre E; Challier B; Weber M; Weber M; Schmutz JL
Rev Med Interne; 1998 Oct; 19(10):709-12. PubMed ID: 9827442
[TBL] [Abstract][Full Text] [Related]
2. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
[TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
4. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
[TBL] [Abstract][Full Text] [Related]
5. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
7. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance.
Ogasawara M; Aoki K; Matsuura E; Sasa H; Yagami Y
Lupus; 1996 Dec; 5(6):587-92. PubMed ID: 9116701
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta 2-glycoprotein I antibodies in Sneddon's syndrome.
Francès C; Piette JC; Viard JP; Tourbah A
Dermatology; 1993; 186(4):273. PubMed ID: 8513196
[No Abstract] [Full Text] [Related]
9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
10. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.
Martinuzzo ME; Forastiero RR; Carreras LO
Br J Haematol; 1995 Feb; 89(2):397-402. PubMed ID: 7873391
[TBL] [Abstract][Full Text] [Related]
11. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
[TBL] [Abstract][Full Text] [Related]
12. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
Kalashnikova LA; Prudnikova LZ; Nasonov EP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunologic features of livedo reticularis in lupus: a case-control study.
Englert HJ; Loizou S; Derue GG; Walport MJ; Hughes GR
Am J Med; 1989 Oct; 87(4):408-10. PubMed ID: 2801732
[TBL] [Abstract][Full Text] [Related]
17. Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies.
El-Kadi HS; Keil LB; DeBari VA
J Rheumatol; 1995 Dec; 22(12):2233-7. PubMed ID: 8835554
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin and anti-beta 2glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome.
Tincani A; Balestrieri G; Spatola L; Cinquini M; Meroni PL; Roubey RA
Clin Exp Rheumatol; 1998; 16(4):396-402. PubMed ID: 9706418
[TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
20. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
